BioSpace News Archive

Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 75,100 shares of common stock and 18,250 restricted stock units to be distributed among seven new employees with a grant date of August 3, 2020.

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced the appointment of Kimberly Tzoumakas, J.D. to its Board of Directors effective July 30, 2020.

Diversicare Healthcare Services, Inc. (OTCQX:DVCR) today announced that it is scheduled to report financial results for its second quarter ended June 30, 2020, on Thursday, August 6, 2020, after the market closes

Rush University System for Health (RUSH) and R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the launch of a joint Innovation Lab to deliver solutions to improve the quality of care for patients on a national scale.

Millennium Dental Technologies, Inc., announces the Reboot Emergency Economic Stimulus Package that will enable doctors to forgo payments for one full year on a PerioLase Periodontal Package™, at no cost to the doctor.

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

IVERIC bio, Inc. reported that on August 3, 2020, the Company granted Dhaval Desai, the Company’s newly hired Chief of Staff, equity based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan.

Avinger, Inc. announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $6 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of Parkinson’s Disease and Movement Disorders (MDS 2020) and the American Neurological Association’s 2020 Annual Meeting (ANA 2020).

Adagio Medical, Inc. announced successful pre-clinical results demonstrating their existing cryoablation catheter is also capable of ablating the tissue through pulsed field ablation delivered via the existing array of electrodes.